Compugen Limited (CGEN) Return on Sales by Net Profit

Brandmark of Compugen Ltd (CGEN)

Compugen Ltd. minimizes capital expenditures by fully outsourcing production and testing. The GURU.Markets terminal displays a net sales margin chart, where the 47.90 level represents the current value. Management efficiency is bolstered by strategic alliances with pharma behemoths to accelerate antibody development, while the stability of the R&D core is ensured by the high loyalty of leading immunologists.

CGEN: cgen.com Company Net Profitability 07/04/2022 - 11/19/2026

Analytical breakdowns for Compugen Ltd.

- market value and analyst target forecast:
Summary company analytics:Compugen Limited - CGEN
Flagship merchandise of cgen.com

Sales margin measures the share of net profit in every dollar of revenue, revealing cost management efficiency and the actual profitability of operating activities. An analysis of net marginal sales income allows for an assessment of how successfully Compugen Ltd. (CGEN) monetizes its developments in computational drug discovery and cancer immunotherapy, confirming the financial stability of this high-tech business.